Actiq 1600 mikrogram sugetabletter Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

actiq 1600 mikrogram sugetabletter

teva pharma b.v. - fentanylcitrat - sugetabletter - 1600 mikrogram

Abstral 200 mikrogram resoribletter, sublinguale Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

abstral 200 mikrogram resoribletter, sublinguale

paranova danmark a/s - fentanylcitrat - resoribletter, sublinguale - 200 mikrogram

Abstral 200 mikrogram resoribletter, sublinguale Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

abstral 200 mikrogram resoribletter, sublinguale

orifarm a/s - fentanylcitrat - resoribletter, sublinguale - 200 mikrogram

Actiq 400 mikrogram sugetabletter Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

actiq 400 mikrogram sugetabletter

teva pharma b.v. - fentanylcitrat - sugetabletter - 400 mikrogram

Actiq 600 mikrogram sugetabletter Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

actiq 600 mikrogram sugetabletter

teva pharma b.v. - fentanylcitrat - sugetabletter - 600 mikrogram

Actiq 800 mikrogram sugetabletter Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

actiq 800 mikrogram sugetabletter

teva pharma b.v. - fentanylcitrat - sugetabletter - 800 mikrogram

Abstral 200 mikrogram resoribletter, sublinguale Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

abstral 200 mikrogram resoribletter, sublinguale

2care4 aps - fentanylcitrat - resoribletter, sublinguale - 200 mikrogram

Abstral 400 mikrogram resoribletter, sublinguale Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

abstral 400 mikrogram resoribletter, sublinguale

2care4 aps - fentanylcitrat - resoribletter, sublinguale - 400 mikrogram

Actiq 600 mikrogram sugetabletter Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

actiq 600 mikrogram sugetabletter

paranova danmark a/s - fentanylcitrat - sugetabletter - 600 mikrogram

Tibsovo Uni Eropa - Dansk - EMA (European Medicines Agency)

tibsovo

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiske midler - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.